NEW YORK (TheStreet) -- CHANGE IN RATINGS
Apple (AAPL) was upgraded at Pacific Crest to outperform from sector perform. Twelve-month price target is $635. Business stagnation has been priced into the stock, Pacific Crest said.
Bank of New York Mellon (BK) was upgraded at UBS to buy from neutral. Driven by rate-driven capital relief, UBS said.
FMC (FMC) was downgraded at Wells Fargo to market perform from outperform. Business split is already priced into the stock, Wells Fargo said.
FMC was downgraded at Piper Jaffray to neutral from overweight. Valuation call, based on a 12-month price target of $87.
J.C. Penney (JCP) was upgraded at Citigroup to buy. Company can likely continue to turn sales around, Citigroup said. Twelve-month price target is $11.Kaman ( KAMN) was upgraded at Drexel Hamilton to buy. Twelve-month price target is $46. Company offers growth at a reasonable price, Drexel Hamilton said.
Macy's (M) was upgraded at Wells Fargo to outperform from market perform. Company is posting strong sales in a challenging environment, Wells Fargo said.
Northern Trust (NTRS) was downgraded at UBS to sell from neutral. Expensive as an asset manager with less flexibility, UBS said.
Stanley Black & Decker (SWK) was upgraded at Wells Fargo to outperform from market perform. Valuation call, based on sum-of-the-parts analysis.
Triumph (TGI) was downgraded at RBC Capital to sector perform from outperform. Twelve-month price target is now $71. Company could face increased charges and business disruptions, RBC Capital said.
Team Health Holdings (TMH) was initiated at UBS with a buy rating. Major beneficiary of health care reform with steady core growth, UBS said. Twelve-month price target is $54.
Wesco Aircraft (WAIR) was upgraded at RBC Capital to outperform from sector perform. Twelve-month price target is $27. Company can grow organically and through acquisitions, RBC Capital said.Stock Comments / EPS Changes
Access Midstream Partners (ACMP) price target, EPS estimates were increased at Jefferies. Shadow backlog and acquisitions could drive incremental cash flow. Twelve-month price target is now $64. Buy rating.
Alexion Pharmaceuticals (ALXN) price target, EPS estimates were increased at UBS. Well-positioned with faster ramp of sales in France and opportunity to lever the operating model, UBS said. Twelve-month price target is now $202. Buy rating.
DDR (DDR) price target was raised at UBS. Sale of Brazil investment removes overhang associated with region's macro issues and supply concerns in the retail real estate market, UBS said. Twelve-month price target is $21. Buy rating.
Kroger (KR) price target, EPS estimates were lifted at UBS. Operating profit upside is coming from fuel, not food. Twelve-month price target is now $43. Neutral rating.
United Natural Foods (UNFI) price target was increased at UBS. Twelve-month price target is now $75. Continued acceleration in independent channel growth, UBS said. Neutral rating.Urban Outfitters ( URBN) numbers were reduced at Nomura. Twelve-month price target is now $39. Estimates also reduced, given challenges at the core retail store, Nomura said. Neutral rating.